‹ ›
MYP_031506
← PREVIOUS NEXT → BACK
Basic Information
HPV-31 L1 Ctb
Antimicrobial
Antiviral
Antiviral ▸ Anti-HPV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Standard
12 amino acids
C60H114N20O17
Standard
Sequence
TTTPAKRKKTKK
Physicochemical Analysis
1387.67 Da
11.39
5.39
5.20
0.4494
-2.22
0.21
-0.79
52.38
8.33
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
647.55
-8.31
24.0
23.0
50.0
97.0
1.0
11.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0054486 VERIFIED: YES
Provenance & Taxonomy
Human papillomavirus [Virus]
Virus-derived peptide
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Human papillomavirus (Virus entry); Cos-7
15 %
Luciferase assay
PaperPositively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity. | Bousarghin L, Touze A, Yvonnet B, Coursaget P. | J Med Virol. 2004 | PMID:15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0157466 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Infection inhibition
Inhibition of pseudovirions infection
7.206 μM
% inhibition
Mammalian: 7.2 h; Yeast: >20 h; E. coli: >10 h
PaperPositively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity. | Bousarghin L, Touzé A, Yvonnet B, Coursaget P. | J Med Virol. 2004 Jul;73(3):474-80. | DOI:10.1002/jmv.20114 | PMID:15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0191322 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
human papillomavirus
12±10 %
Inhibition
PaperPubMed PMID: 15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0243599 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0297400 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
inhibition of pseudovirions infection
15±8 %
Inhibition
PaperPubMed PMID: 15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2